Analystreport

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $20.00 to $10.00.

Karyopharm Therapeutics Inc.  (KPTI) 
Last karyopharm therapeutics inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.karyopharm.com/investor-relations